Compared with the results reported from countries other than China, the proportion of patients with 3M syndrome and mutations of the OBSL1 gene is higher in the Chinese population, while the proportion of those with CDCC8 mutations is lower (Huber et al., 2019; Simsek-Kiper et al., 2019). This evidence concerns the gene OBSL1 and 3-M syndrome.